The recent flexibility and deregulation of the pharmaceutical sector in the Ukrainian and Iranian markets have created major business and/or productive opportunities for European pharmaceutical companies. For this reason, WBTC GROUP analyses, plans, manages and undertakes business and/or productive initiatives in this sector.
Bearing this in mind, WBTC GROUP has its own structure in the target country, linked to a network of collaborators with experience in the sector and who are market leaders.

The following areas of action are worthy of mention:

Pharmaceutical targeting, marketing and distribution, registration of medicines, search for distribution channels, search for business and/or technological partners.

Manufacturing contracts, production centre linked to WBTC GROUP “Pharma Start LLC.” Kiev, (Ukraine), production capacity: 1 billion tablets and 250 million capsules. GMP EU certificates.